BMO Capital analyst Daniel Jester raised the firm’s price target on Ceridian to $86 from $73 and keeps an Outperform rating on the shares after its Q4 earnings beat. The company offers a path to top-line improvement in the second half of the year as up-market go-lives grow, along with more clarity on the Wallet and an attractive long-term global opportunity, the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CDAY:
